CQP(SZ:000950) Xin Lang Cai Jing·2025-08-21 01:40Core Insights - The company reported a total operating revenue of 41.188 billion yuan, an increase of 1.409 billion yuan compared to the same period last year, representing a year-on-year growth of 3.54% [1] - The net profit attributable to shareholders reached 282 million yuan, an increase of 44.177 million yuan from the same period last year, reflecting a year-on-year increase of 18.56% [1] - The net cash flow from operating activities was -2.273 billion yuan, an improvement of 1.386 billion yuan compared to the same period last year, marking two consecutive years of increase [1] Financial Ratios - The latest debt-to-asset ratio stands at 75.61%, a decrease of 0.05 percentage points from the previous quarter and a decrease of 0.67 percentage points from the same period last year [3] - The latest gross profit margin is 7.31%, an increase of 0.11 percentage points from the previous quarter [3] - The latest return on equity (ROE) is 2.45%, an increase of 0.36 percentage points from the same period last year [3] Earnings Per Share - The diluted earnings per share (EPS) is 0.16 yuan, an increase of 0.02 yuan compared to the same period last year, representing a year-on-year increase of 14.29% [3] Asset Management - The latest total asset turnover ratio is 0.61 times, and the inventory turnover ratio is 3.77 times [4] Shareholder Structure - The number of shareholders is 43,800, with the top ten shareholders holding a total of 1.107 billion shares, accounting for 64.06% of the total share capital [4] - The largest shareholder is Chongqing Pharmaceutical Health Industry Co., Ltd., holding 38.47% of the shares [4]